Valneva Said to Be Near EU Vaccine Deal After Talks Resume

Company previously abandoned talks, preferring bilateral deals
Inactivated shot could better protect against new variants

A lab technician inspects a bottle containing growth media for virus production during coronavirus vaccine research at the Valneva laboratories in Vienna in 2020. — A lab technician inspects a bottle containing growth media for virus production during coronavirus vaccine research at the Valneva laboratories in Vienna in 2020.
Photographer: Akos Stiller/Bloomberg

Provide news feedback or report an error

Confidential tip?

Send a tip to our reporters

Take our Survey

By Alberto Nardelli and Suzi Ring

June 30, 2021 at 11:52 AM UTC

Updated on

June 30, 2021 at 2:50 PM UTC

This article is for subscribers only.